Maynard Um
-
-
-
-
-
-
-
Allogene (ALLO) PT Lowered to $11 at H.C. Wainwright
-
-
-
-
-
-
-
Allogene (ALLO) PT Raised to $8 at Citizens
-
-
-
-
-
-
-
Citizens on Allogene (ALLO): 'We View Shares as an Attractive Investment Opportunity'
-
-
-
-
-
-
-
Allogene to present ALPHA3 trial data at ASH annual meeting
-
-
-
-
-
-
-
Allogene drops experimental drug from lymphoma trial after patient death
-
-
-
-
-
-
-
Allogene (ALLO) PT Lowered to $8 at H.C. Wainwright
-
-
-
-
-
-
-
Biotech outlook for 2025: Stifel
-
443,944 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

